- Leo Petrossian, CEO, Neural Analytics
- Michael E. Jung, Distinguished Professor of Chemistry, Biochemistry & Organic Chemistry, UCLA
- Jeff Silverman, Corporate Vice President, Celgene
- Ed Baracchini, CBO, Xencor
- Neelima Firth, Principal, Best Laid Plans, Inc.
- Monica Alfaro Welling, Managing Director, Atheln, Inc.
- Will de Groot, Investor
- Stan Tomsic, Managing Director, Magna Point Group
- John Lasko, Entrepreneur & Advisor
- Gerard Jensen, Senior Director of Technical Services, Gilead Sciences, Inc.
- Jill Adler-Moore, Emerita Professor of Microbiology, Cal Poly Pomona
- Ed Beres, Technology Transfer Officer, UCLA Technology Devolopment Group
- Jessica Rousset, CBO, CURE Pharmaceutical Corp.
- Ronald Allen, President, Global Regulatory Affair
- Gary Fujii, President & CEO, Molecular Express, Inc.
- Alan Crunkleton, President & CEO, TriFoil Imaging
- David H. Crean, Managing Director for Healthcare & Life Sciences, Objective Capital Partners
- Pamela Contag, CEO, BioEclipse Therapeutics
- Todd Peterson, CTO, Synthetic Genomics
- Will Sarat Chuchawat, Partner – M&A Team Leader, Shepard Mullin Richter & Hampton LLP
- Dave Moon, Managing Director, Radius 2.0; Director and Professor of Art, CSUN
- Dax Stephens, Corporate Attorney & Business Advisor
- Seth D. Levy, Managing Partner, Los Angeles Office, and Co-chair, Life Sciences Practice, Nixon Peabody
- Matt Grazier, Partner, Private Equity & Investment Funds, Nixon Peabody
- Jill Gordon, Partner, Health Law & Life Sciences, Nixon Peabody
- Michael Lindsay, Partner, Labor & Employment Law, Nixon Peabody
- Gabrielle Goldstein, Counsel, Biomedical Regulatory & Compliance, Nixon Peabody
- Erik Birkeneder, Associate, Intellectual Property, Nixon Peabody
- Jack Rose, Associate, Private Equity & Investment Funds, Nixon Peabody
- Daniel Eliav, Associate, Health Care, Nixon Peabody
- Erin Holyoke, Associate, Labor & Employment Law, Nixon Peabody
- Bassil I. Dahiyat, President & CEO, Xencor